News for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)

PR NewswireSHANGHAI, Feb. 26, 2025 Bringing New Hope to Chinese Dialysis Patients with HyperphosphatemiaSHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fo

Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia

PR NewswireSHANGHAI, Feb. 17, 2025 SHANGHAI, Feb. 17, 2025 /PRNewswire/ -- Nowadays, artificial intelligence (AI) technology is profoundly reshaping the la

SHANGHAI, Feb. 17, 2025 /PRNewswire/ -- Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare industry. As a global innovation-driven pharmaceutical and healthcare group, Fosun Pharma places great emphasis on the transformative potential of AI technology in the pharmaceutical and healthcare sectors. The company actively embraces AI technology, deploying it in areas such as drug research and development, medical imaging, and precision medicine through both independent research and external collaborations, thereby driving transformation and development in the pharmaceutical industry through technological advancements. At the same time, Fosun Pharma is accelerating the deeper application of AI technology in marketing, customer service, and smart office solutions, using AI to improve quality and efficiency while promoting enhanced corporate management effectiveness.

Intuitive Surgical Inc (ISRG) leads with innovative robotic-assisted surgical systems, facing competitive and regulatory challenges.Financial resilience showca

SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the ”œCompany”) ( ISRG), a global technology leader in minimally invasive care and the pion

**media[522912]**

**media[515974]**

SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the ”œCompany”) ( ISRG), a global technology leader in minimally invasive care and the pion

Fosun Pharma Announces 2024Q3 Financial Results

Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen

Cosmetic Lasers Market to Surge as Demand for Standalone Lasers Grows, Offering Precision Treatments with Single Wavelength Technology...

An overview of the investment merits and risks of SpringWorks Therapeutics, highlighting pipeline advancements and operational liquidity. Read more here.

SHENZHEN, China, July 30, 2024 /PRNewswire/ -- Shenzhen Synthetica Pioneering Co., Ltd. (Synthetica), a biotech startup specializing in synthetic biology for engineering novel living bacterial therapeutics, has recently closed a Series A funding round, led by Boehringer Ingelheim Venture Fund and Temasek, with additional participation from Lenovo Capital, Fosun Health Capital and ATLATL Summer Fund. The funding will be used to fast-track Synthetica's oncolytic bacterial pipelines into clinical trials.

/PRNewswire/ -- 2023 ESG Global Leaders Conference was held at the Greenland Bund Center in Huangpu District, Shanghai from September 13 to 15, with the theme...

The global dermatology excimer laser market was valued at USD 429.11 million in 2021 and is predicted to reach at USD 1040.32 million by 2030, increasing...

SHANGHAI, Aug. 29, 2023 /PRNewswire/ -- On August 29, 2023, Shanghai Fosun Pharmaceutical Co., Ltd.* announced its 2023 Interim Results for the first half of 2023. . During the Reporting Period,...

/PRNewswire/ -- On August 29, 2023, Shanghai Fosun Pharmaceutical Co., Ltd.* (Stock Code: 600196.SH; 02196.HK) announced its 2023 Interim Results for the first...

/PRNewswire/ -- The global heparin market size is estimated to grow by USD 3,009.44 million from 2022 to 2027, according to Technavio. The market is estimated...